Search Results for: A-

alpha-lipoic acid

A substance that is being studied for its ability to protect normal cells from the side effects of chemotherapy and prevent peripheral neuropathy (numbness, … [Read more...]

L-arginine / Korean ginseng / Gingko biloba / damiana-based supplement

An amino acid and herbal supplement with libido-enhancing activity. L-arginine/korean ginseng/Ginkgo biloba/damiana-based supplement contains a blend of the … [Read more...]

indium In-111-DOTA-di-HSG peptide IMP-288

A radiolabeled divalent histamine-succinyl-glycine (HSG) hapten-peptide linked with the macrocyclic chelator 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic … [Read more...]

alpha-adrenergic antagonist

A substance that relaxes muscle tissue in blood vessels and in the prostate gland, which improves the flow of urine and blood. Alpha-adrenergic antagonists are … [Read more...]

PEG-interferon alfa-2a

A covalent conjugate of recombinant interferon alfa, subtype 2a, and polyethylene glycol (PEG), used as an antiviral and antineoplastic agent. The biological … [Read more...]

autologous NY-ESO-1-melanoma-specific CD8+ T cells

A preparation of autologous CD8+ (cytotoxic) T-lymphocytes sensitized to cancer-testis antigen NY-ESO-1 antigen with potential immunostimulating and … [Read more...]

HER-2-neu, CEA peptides, GM-CSF, Montanide ISA-51 vaccine

A vaccine comprised of HER-2-neu and carcinoembryonic antigen synthetic (CEA) peptides, combined with the adjuvants granulocyte-macrophage colony stimulating … [Read more...]

fowlpox-PSA-TRICOM vaccine

A cancer vaccine consisting of a recombinant fowlpox virus encoding human prostate-specific antigen (PSA) and TRICOM, a combination of three immunostimulants … [Read more...]

99mTc-DTPA-mannosyl-dextran

A radiolabeled macromolecule consisting of the chelating agent diethylenetriamine pentaacetic acid (DTPA) and mannose each attached to a dextran backbone and … [Read more...]

anti-DR5 agonist monoclonal antibody TRA-8

An agonist mouse monoclonal antibody directed against TRAIL death receptor type 5 (DR5) with potential antineoplastic activity. Anti-DR5 agonist monoclonal … [Read more...]